Literature DB >> 26312837

The role of TP53 in miRNA loading onto AGO2 and in remodelling the miRNA-mRNA interaction network.

Jonathan Krell1, Justin Stebbing2, Adam Enver Frampton3, Claudia Carissimi4, Victoria Harding2, Alexander De Giorgio2, Valerio Fulci4, Giuseppe Macino4, Teresa Colombo5, Leandro Castellano2.   

Abstract

BACKGROUND: DNA damage transactivates tumour protein p53 (TP53)-regulated surveillance, crucial in suppressing tumorigenesis. TP53 mediates this process directly by transcriptionally modulating gene and microRNA (miRNA) expression and indirectly by regulating miRNA biogenesis. However, the role of TP53 in regulating miRNA-AGO2 loading and global changes in AGO2 binding to its gene targets in response to DNA damage are unknown. These processes might be novel mechanisms by which TP53 regulates miRNAs in response to DNA damage.
METHODS: To show the network of miRNA-mRNA interactions that occur in response to DNA damage, we stimulated TP53 wild-type and null cell-lines with doxorubicin and performed RNA sequencing from total RNA (RNA-Seq) and AGO2-immunoprecipitated RNA (AGO2-RIP-Seq). We used a combined AGO2 RIP-seq and AGO2 PAR-CLIP-seq (photoactivatable-ribonucleoside-enhanced cross-linking and immunoprecipitation) approach to determine the exact sites of interaction between the AGO2-bound miRNAs and their mRNA targets.
FINDINGS: TP53 directly associated with AGO2, and induced and reduced loading of a subset of miRNAs, including the lethal 7 (let-7) miRNA family members, onto AGO2 in response to DNA damage. Although mutated TP53 maintained its capacity to interact with AGO2, it mediated unloading instead of loading of let-7 family miRNAs, thereby reducing their activity. We determined the miRNA-mRNA interaction networks involved in the response to DNA damage both in the presence and absence of TP53. Furthermore, we showed that miRNAs whose cellular abundance or differential loading onto AGO2 was regulated by TP53 were involved in an intricate network of regulatory feedback and feedforward circuits that fine-tuned gene expression levels in response to DNA damage to permit the repair of DNA damage or initiation of programmed cell death.
INTERPRETATION: Control of AGO2 loading by TP53 is a new mechanism of miRNA regulation in carcinogenesis. FUNDING: UK Medical Research Council, Action Against Cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2015        PMID: 26312837     DOI: 10.1016/S0140-6736(15)60330-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  The Complex Interaction between P53 and miRNAs Joins New Awareness in Physiological Stress Responses.

Authors:  Camilla Capaccia; Silvana Diverio; Danilo Zampini; Gabriella Guelfi
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

2.  Circular RNA circRPPH1 promotes triple-negative breast cancer progression via the miR-556-5p/YAP1 axis.

Authors:  Yehui Zhou; Xiaorong Liu; Jing Lan; Yuqiu Wan; Xun Zhu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Prognostic value of DNA repair based stratification of hepatocellular carcinoma.

Authors:  Zhuo Lin; Shi-Hao Xu; Hai-Qing Wang; Yi-Jing Cai; Li Ying; Mei Song; Yu-Qun Wang; Shan-Jie Du; Ke-Qing Shi; Meng-Tao Zhou
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

4.  Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis.

Authors:  Honglei Wang; Yi Xiao; Li Wu; Dachang Ma
Journal:  Int J Oncol       Date:  2018-02-05       Impact factor: 5.650

Review 5.  Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".

Authors:  Katia Grillone; Caterina Riillo; Francesca Scionti; Roberta Rocca; Giuseppe Tradigo; Pietro Hiram Guzzi; Stefano Alcaro; Maria Teresa Di Martino; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  J Exp Clin Cancer Res       Date:  2020-06-20

6.  The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.

Authors:  Marco Napoli; Elsa R Flores
Journal:  RNA Biol       Date:  2020-01-07       Impact factor: 4.652

7.  Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis.

Authors:  Yana Lu; Yihang Li; Guang Li; Haitao Lu
Journal:  Mol Med Rep       Date:  2020-06-26       Impact factor: 2.952

8.  MicroRNA Dysregulation in Prostate Cancer.

Authors:  Vlad Horia Schitcu; Lajos Raduly; Andreea Nutu; Oana Zanoaga; Cristina Ciocan; Vlad Cristian Munteanu; Roxana Cojocneanu; Bogdan Petrut; Ioan Coman; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Pharmgenomics Pers Med       Date:  2022-03-10

9.  Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis.

Authors:  Martha L Slattery; Jennifer S Herrick; Lila E Mullany; Erica Wolff; Michael D Hoffman; Daniel F Pellatt; John R Stevens; Roger K Wolff
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

10.  Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.

Authors:  Dan Jin; Jiwei Guo; Yan Wu; Weiwei Chen; Jing Du; Lijuan Yang; Xiaohong Wang; Kaikai Gong; Juanjuan Dai; Shuang Miao; Xuelin Li; Guoming Su
Journal:  J Exp Clin Cancer Res       Date:  2020-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.